Product Information
KETOCONAZOLE 2% FOAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $5.6921 per GM under NDC 45802053232. Its NADAC has been published 157 times since Nov 28, 2013.
FDA first approved this application on Aug 25, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the ketoconazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 g/100g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802053232
Classification
Generic
Dosage Form
AEROSOL, FOAM
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
KETOCONAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA091550FDA Approved
8/25/2011
TE Code
AB
On Market Since
8/30/2011
Pharmacological Classes
Price Statistics
The NADAC for KETOCONAZOLE 2% FOAM has been published 157 times since Nov 28, 2013, and over the history we have for it it has risen 64.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.6921 per GM |
|---|---|
| All-time high | $8.0876 (Dec 11, 2024) |
| All-time low | $3.4637 (Nov 28, 2013) |
| 52-week high | $6.3867 |
| 52-week low | $5.2798 |
| Median price | $6.0486 |
| Average price | $5.7935 |
| Largest weekly change | +92.7% (Apr 17, 2024) |
| Weeks tracked | 157 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of KETOCONAZOLE 2% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for KETOCONAZOLE 2% FOAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $5.6921 per GM (NDC 45802053232), effective Aug 19, 2026.
How has the price of KETOCONAZOLE 2% FOAM changed over time?
Over the history we have for it, the NADAC for KETOCONAZOLE 2% FOAM has risen 64.3%. It has been tracked across 157 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for KETOCONAZOLE 2% FOAM?
Since Nov 28, 2013, the NADAC for KETOCONAZOLE 2% FOAM has ranged from a low of $3.4637 (Nov 28, 2013) to a high of $8.0876 (Dec 11, 2024), with a median of $6.0486 per GM.
Are there cheaper alternatives to KETOCONAZOLE 2% FOAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KETOCONAZOLE 2% FOAM, is $3.2761 per GM — about 42% below KETOCONAZOLE 2% FOAM.
Who manufactures KETOCONAZOLE 2% FOAM?
KETOCONAZOLE 2% FOAM (NDC 45802053232) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.